T hymocytes consist of four major CD4-8-, CD4+8 +, CD4+8-, and CD4-8 + populations. CD4-8-thymocytes are thought to be potent progenitors that develop into mature CD4 + 8 -or CD4-8 + thymocytes through CD4 + 8 + thymocytes. However, in adult mice of most strains, ~10-20% of the CD4-8-thymocytes expresses low levels of TCR-c~/~/ (TCR-od~ low) (1, 2) . The CD4-8-TCRa/fl l~ population has a phenotype similar to that of memory T cells (i.e., CD44 +, intercellular adhesion molecule 1+, MEL-14-Thy-l+, CD5 + and heat-stable antigen [HSA]-I) (3, 4) . Interestingly, '~40-50% of the CD4-8-TCR-cr/B l~ thymocytes expresses VB8.2 TCR (1, 2, 4, 5), whereas only ~10--20% of cells in ordinary CD4+8 -or CD4-8 § population bearing high levels of TCR-od~ 1 Abbreviations used in this paper'. HSA, heat-stable antigen; LN T, lymph node T cells.
(TCR-~/~ high) express the V~8.2 TCR. The CD4-8-TCR-oL/~ l~ thymocyte population can proliferate and secrete several kinds of lymphokines upon stimulation via the TCR (6) (7) (8) . Furthermore, it has been reported that the CD4-8-TCR-od~ l~ thymocytes express NKI.1 antigens in mice of NKI.1 type (4, 9). The NKI.1 § antigens are not expressed on major classical T cells and have been thought to be a specific marker for NK cells (10, 11) . The number of CD4-8-NKI.1 + TCR-c~//5 l~ thymocytes increases with age and they become a substantial population at relatively late stages in life (1, 5) . On the other hand, we have recently found a NKI.1 + TCR-od/~/l~ subpopulation in a CD4+8 -thymocyte population (12, 13) . The NKI.1 § CD4+8-thymocytes show characteristics similar to those of NKI.1 + CD4-8-TCR<x/B l~ thymocytes in their surface phenotype, TCR V~ usage, lymphokine production profile, and ontogeny, although lineage correlation between these two subpopulations has remained unclear.
In our subsequent study (3) , we demonstrated that NKI.1 + TCR-ot//5 L~ thymocytes express IL-2 receptor 3 chain and proliferate upon stimulation with recombinant IL-2. Furthermore, after stimulation with recombinant IL-2 the NKI.1 + TCR-ot/3 l~ thymocytes acquired cytotoxic activity against both normal thymocytes and several kinds of tumor cells. Therefore, the NKI.1 + TCR-ot/3 l~ thymocytes seemed to be of functional T cell lineage. However, when freshly isolated NKI.1 + TCR-a/3 l~ thymocytes were evaluated in a 4-h cytotoxic assay, we could not detect significant cytotoxicity. Thus, physiological function of the NKI.1 + TCR-ot/3 l~ thymocytes was not uncovered.
On the other hand, it has been demonstrated that most of the thymocytes express considerable Fas antigens that transduce signals for apoptosis into cells (14, 15) . The Fas antigen is encoded by the gene at the locus of the mouse lymphoproliferation mutation tpr (16) . Since mice carrying mutations homozygous at the lpr locus and actually lacking the Fas expression have lymphadenopathy and autoimmune diseases, it seems that the expression of the intact Fas antigen is related to the physiological development of T cells in normal mice. However, the mechanism how the Fas antigen is involved in the normal T cell development has been unclear. Identification of cells expressing Fas ligand, if present, in the thymus seems important to clarify the direct function of the Fas antigen in physiological conditions.
In the present study, to elucidate the function of NKI.1 + TCR-ot/31~ thymocytes, we analyzed the cytotoxicity of freshly isolated NKI.1 + TCR-cr/3 l~ thymocytes against thymocyte targets by using a long-term cytotoxic assay. We found that the freshly isolated NKI.1 § TCR-c~/3 l~ thymocytes exhibited considerable cytotoxicity against CD4+8 + thymocytes. Furthermore the cytotoxicity was directly correlated with the intact Fas expression and Fas ligand expression on the targets and effector cells, respectively. Thus, the NKI.1 + TCR-a/3 l~ thymocyte population seems to represent a population that regulates thymocyte development via Fas antigen and Fas ligand interaction.
Materials and Methods
Mice. C57BL/10 (B10), B10.BR/SgSnSIc (B10.BR) mice were obtained from the Shizuoka Laboratory Animal Cooperation (Hamamatsu, Shizuoka Prefecture, Japan). C57BL/6J Jcl were obtained from the Japan Clea Animal Cooperation (Tokyo, Japan). B6 Ipr/Ipr and B6 gld/gld were obtained from stock maintained in our animal facility at Hokkaido University.
Antibodies andRea,gents. Primary n'tAbs used for immunofluorescence staining and flow cytometry in the present experiments were 2Cll (anti-CD3-e, a kind gift from Dr. J. A. Bluestone, University of Chicago, Chicago, IL) (17) 
CA).
Surface Marker Analysis. Thymocytes were treated with anti-HSA mAb or mixture of anti-HSA and anti-CD8 mAbs followed by C treatment. The resultant cells were treated with Dynabeads coupled with anti-mouse or anti-rat IgG (Dynal, Oslo, Norway) to completely remove CD8 + or HSA + cells. Thereafter, the purified HSA-cells were stained with anti-NKl.1 mAb or medium followed by biotin anti-mouse IgG and TANDEMstreptavidin. After blocking the nonspecific binding site of anti-mouse IgG by purified mouse Ig, the cells were stained with PE anti-CD4 and FITC anti-CD8 mAbs (Fig. 1) . On the other hand, the purified HSA-CDS-cells were mixed with anti-NKI.1, MEL-14, anti-CD4 mAb, or medium (control) followed by PE anti-mouse IgG or PE anti-rat IgG. After blocking the nonspecific binding site of anti-mouse IgG or anti-rat IgG by purified mouse or rat Ig, the cells were mixed with anti-CD3 mAb or anti-TCR-c~/3 mAb followed by FITC anti-hamster IgG that had been preabsorbed with mouse and rat Ig (Fig. 2) . The Cytotoxic Assay. Target thymocytes were prepared from syngeneic 1-4-wk-old mice unless otherwise indicated. CD4 § + target thymocytes were prepared by sorting. HSA-NKI.1-target thymocytes were prepared by treatment with anti-HSA + anti-NKI.1 mAb plus C followed by Dynabead treatment. Cytotoxic assay was carried out as previously reported (3, 22) . Briefly, target cells were labeled with PKH-2 green fluorescence dye (Zynaxis Cell Science, Inc., Malvern, PA) and were mixed with various numbers of effector ceils for 16 or 10 h in a V-bottomed 96-well microplate (Flow Laboratories, Inc., McLean, VA) in 200 #1 of RPMI 1640 supplemented with 10% FCS, penicillin (100 U/ml), streptomycin (100 #g/ml), and 5 x 10 -s M 2-ME after centrifuge. Thereafter, the proportion of dead cells among PKH-2-stained cells were analyzed by staining the cultured cells with propidium iodide red fluorescence dye (Sigma Chemical Co., St. Louis, MO) using FACScan | In our preliminary experiments with tumor cell targets, no difference was observed between this PKH-2 staining method and the S'Cr release assay. Data are presented as mean _+ SD from triplicate cultures.
Induction ofAnti-H.2 d CTL.
Anti-H-2 d cytotoxic T cells were generated by stimulating purified B10.BK lymph node T cdls with 20-Gy irradiated B10.D2 splenocytes for 4 d (23). Cytotoxicity was determined by a 5-h assay as described above.
Fas Antigen Transfectants. The cDNA encoding the truncated mouse Fas antigen (90 amino acids had been removed from the COOH-terminal end) was obtained by reverse transcription PCK using an oligonucleotide corresponding to nucleotides 27-46 and 740-760 of the published sequence (24) . L5178Y cells were cotransfected with EcoRI-digested pMAMneo (Clontech Laboratories, Inc., Palo Alto, CA), and PvuI-digested pME18S (25) 
Results

Su~ace Marker Analrsis of NKI.1 + TCR-oe/~ + Thymocytes. NKI.1 + TCR-ot/~ l~ thyrnocytes have been reported
to be present in HSA-CD4-8-(1, 2, 4, 9) or HSA-CD4 + 8-population (12, 13) . However, direct comparison of CD4 and CD8 expressions on the NKI.1 + cells has not been performed. To clarify the surface characteristics of NKI.1 + T cells, we first analyzed expressions of NKI.1 antigen on HSA-thymocytes. As shown in Fig. 1 A, ~12% of HSA-thymocytes expressed NKI.1 antigens. When CD4 and CD8 expressions on HSA-NKI.1-or HSA-NKI.1 + cells were analyzed by three-color flow cytometry, only CD4 + 8-and CD4-8 § populations were seen among the HSA-NKI.1-cells ( Fig. 1 B) . By contrast, HSA-NKI.1 + cells were revealed to consist of CD4+8 -and CD4-8-populations. Actually no NKI.1 + ceils were detected in CD4 + 8 + and CD4-8 + thymocyte populations.
We then analyzed expressions of NKI.1, MEL-14, or CD4 antigens on CD8-HSA-thymocytes in combination with CD3 or TCP,-ot/3 expression. The CD8-HSA-thymocytes consisted of CD3/TCR-ot/3 l~ and CD3/TCROt//3hi8 h populations (Fig. 2, A and E). More than 99% and more than 98% of the NKI.1 § CD8-HSA-cells expressed low levels of CD3 and TCR-ot/3, respectively ( 
Cytotoxicity of Freshly Isolated NKI.I + TCR-cr/~ ~ T~mo-cytes against Thyrnocyte
Targets. In our previous study (3), we found that NKI.1 + CD4-8-TCR-ot/3 l~ thymocytes exhibited considerable LAK activity against thymocytes in a 4-h cytotoxic assay. However, we could not detect cytotoxicity in freshly isolated NKI.1 + CD4-8-TCR-ot/3 l~ thymocytes in the 4-h cytotoxic assay. Since we observed in this study (3) that the NKI.1 § CD4-8-TCR-od3 l~ thymocytes showed significant redirected cytotoxicity against tumor cells bearing Fc receptors before these cells acquired LAK activity, we attempted to detect cytotoxic activity of freshly isolated thymocyte subpopulations using different experimental conditions. When cytotoxicity of purified CD4-8-HSA-MEL-14-(double negative, DN) and CD4+8 -HSA-MEL-14-(CD4) thymocytes, most of which were NKI.1 § cells, was evaluated against thymocyte targets in a 16-h cytotoxic assay, both of these two populations exhibited considerable cytotoxicity toward syngeneic thymocytes (Fig. 3 A) . The cytotoxicity, however, was low when evaluated in a 10-h cytotoxic assay (Fig. 3 B) . On the other hand, neither unfractionated (whole) thymocytes nor lymph node T cells (LN T) showed any killing activity toward thymocytes (Fig. 3 A) . In addition, lymph node T cell blasts induced by stimulation with immobilized anti-TCR mAbs showed no cytotoxicity against thymocyte targets (data not shown).
We then sorted CDS-HSA-thymocytes into NKI.1 § lymph node T cells (LN/T) and NKI.1-or into TCRod3 I~ and TCR.-oe/~ high populations to confirm the population that is responsible for the cytotoxicity. Fig. 3 C shows that NKI.1 § or TCR-od~ l~ population but neither NKI.1-nor TCR,-ot/~ high population possesses significant cytotoxic activity. From these observations, we conduded that only NKI.1 + TCR-od3 l~ cells among CD8-HSAthymocytes exhibit substantial cytotoxicity against syngeneic thymocytes.
Thymocyte Subpopulation Susceptible to the Cytotoxicity by NKI.1 + TCR-cr/I~ l~ Thymocytes. Next, to determine the population that is susceptible to the cytotoxicity by NKI.1 + TCR-oe/3 l~ thymocytes, we prepared CD4 + 8 + (double positive, DP) cells as a representative of immature thymocyte targets, HSA-NKI.1-(HSA-) cells as a representative of mature thymocyte targets and LN T as a representative of mature peripheral T cell targets. NKI.1 + CD4-8-TCRor/3 l~ thymocytes killed CD4+8 + thymocytes (Fig. 4 A) .
By contrast, these NKI.1 + TCR-od3 l~ cells killed neither mature HSA-NKI.1-thymocytes nor LN T. Similarly, the NKI.1 + TCR.-o//• l~ thymocytes showed no cytotoxicity against NKI.1-CD4-8-thymocytes, although almost half of the CD4-8-population was dead spontaneously in the 16-h culture either in the absence or presence of effector cells (data not shown). These observations may permit us to conclude that cells killed by the NKI.1 § TCR-oe//3 t~ thymocytes are CD4 +8 + thymocytes.
When the susceptibility of target thymocytes to NKI.1 + effector cells was compared between young mice (1 wk old) and adult mice (12 wk old), thymocytes from young mice constantly showed higher susceptibility to the NKI.1 + thymocytes than those from adult mice did (Fig. 4 B) . On the other hand, no significant difference was observed in proportion of CD4+8 + thymocytes between young and adult mice (data not shown). This finding suggests that proportion of the CD4 + 8 + subpopulation susceptible to the cytotoxicity by NKI.1 § killer cells is high in the thymus of young mice as compared with adult mice. Therefore, we used thymocytes from young mice as targets throughout the present study unless otherwise indicated.
Requirement of Fas Expression on the Targets for Susceptibility to the Cytotoxicity by NKI.1 + TCR-ce/fl t~ Thymocytes.
We then analyzed influence of genetic differences on the susceptibility of thymocyte targets to NKI.1 + TCR-ot/3 l~ thymocytes. CD8-HSA-NKI.1 + thymocytes, in which >98% of the cells were TCR-c~/3 l~ from B10.BR (H-2 k) mice killed both H-2 compatible (B10.BR) and H-2 incompatible (B10) (H-2 b) thymocytes (Fig. 5 A) . Thus, it appeared that H-2 differences between killer and target cells did not influence the cytotoxicity. However, it should be noted in Fig. 5 ionophor (26, 27) was compared between B6 +/+ and B6 lpr/Ipr mice, both B6 +/+ and B6 Ipr/lpr thymocytes showed the same levels of susceptibility to the calcium ionophor (Fig.  5 C) . Furthermore, no difference in the proportion of major thymocyte subpopulations was noted between young normal (+/+) and young Ipr mice (Fig. 6 ). Expression patterns of MHC class I and LFA-1 molecules on thymocytes were essentially identical between these mice (data not shown).
Recently, the Ipr gene has been identified as a mutation in j~s gene that encodes Fas antigen that transduce signals to induce apoptosis (14-16). Indeed, it has been reported that the Fas antigen is not expressed on the surface of thymocytes
from Ipr mice, although most of thymocytes from normal counterpart mice (congenic at the lpr locus) express the Fas antigen at high levels (15, 28, 29) . Thus, the present findings that NKI.1 + TCR-ot/~ l~ thymocytes exhibited substantial cytotoxicity only toward thymocyte targets of normal mice but not those of Ipr mice suggest that the cytotoxicity is associated with the Fas expression on the targets.
Cytotoxicity of NKI.1 + TCR-cr/fl ~ Thymocytes toward Target Cells Transfected with fas Genes.
Next, to examine directly the involvement of Fas antigens on the cytotoxicity, we analyzed cytotoxicity of NKI.1 + TCR-ot//3 l~ thymocytes against target cells transfected with j~s gene. L5178Y (a T lymphoma line derived from DBA/2) cells were transfected with either wholeJas cDNA or mutatedj~s cDNA in which cytoplasmic domain is truncated (90 amino acids had been removed from the COOH-terminal end). Fig. 7 shows that the parental L5178Y cells do not express Fas antigen. By contrast, J~s gene transfectants (A-l) or mutant Jhs gene transfectants (F-10) express significant amounts of Fas antigens on their surface. When these cells were used as targets, NKI.1 + thymocytes from B10.BR mice killed A-1 transfectants more extensively than parental L5178Y cells or F-10 transfectants (Fig. 8 A) . On the other hand, these transfectants and parental cells showed the same level of susceptibility to the cytotoxicity by anti-H-2 a CTL (Fig. 8 B) . Thus, the difference in susceptibility to NKI.1 + TCR-od3 l~ thymocytes seen among three target cell lines appears not to be attributable to their different sensitivities to the cytotoxic agents. It seems that intact Fas expression on the targets is directly associated with the susceptibility to NKI.1 + TCR-c~/3 l~ thymocytes. We then, purified NKI.1 § cells from the thymus of gld mice and analyzed their cytotoxicity against thymocyte targets. Fig. 9 A shows that the NKI.1 + thymocytes from gld mice do not kill thymocyte targets from normal mice. On the other hand, when susceptibility of target thymocytes to the NKI.1 + effector cells from normal (B6 +/+) mice was compared between gld mice and normal mice, thymocytes from gld mice showed slightly but consistently higher susceptibility than those from normal mice (Fig. 9 B) . These results support interpretation for our present experimental results that NKI.1 + TCR l~ thymocytes kill targets at least in some part via Fas antigen-Fas ligand interaction.
Cytotoxic Activity of Ng1.1 + TCR-cr/~ t~
Discussion
NKI.1 § TCI~-oJ3 l~ thymocytes are detected in both CD4-8-and CD4 + 8-thymocyte populations (4, 9, 12) . In spite of extensive analysis of this population, physiological role of the NKI.1 § TCR-od3 l~ thymocytes has been unclear. In the present study, using a 16-h cytotoxic assay we demonstrated that freshly isolated NKI.1 + TCR-od3 l~ thymocytes exhibited significant cytotoxicity against thymocyte targets from either syngeneic or allogeneic mice. Furthermore, the target population susceptible to the killing activity by NKI.1 + TCR-a/[3 l~ thymocytes was revealed to be immature CD4+8 + thymocytes. Although it took a long time (16 h) for the NKI.1 + TCR-a/B 1~ thymocytes to express detectable levels of cytotoxicity against CD4+8 § thymocytes in vitro as compared with conventional CTL, NK, or LAK cells, it seems interesting and somewhat surprising that effector (killer) cells and their target cells are coexisting within the same organ: the thymus.
Furthermore, we found that NKI.1 + TCR-od3 l~ thymocytes did not exhibit significant cytotoxicity against CD4 + 8 + thymocytes from Ipr mice. The Ipr mice have recently been reported to carry mutatedfas gene in which early transposon is inserted (16, (36) (37) (38) . In fact extensively low levels of Fas expression are noted on thymocytes in Ipr mice (15, 29) . Thus, the present finding that thymocytes from Ipr mice but not from +/+ normal mice were resistant to cytotoxicity by NKI.1 + TCR-oe/fl l~ thymocytes suggests the involvement of Fas antigen in the cytotoxicity. Furthermore, NKI.1 + TCR-ol/3 l~ cells killed the T lymphoma line transfected with jas genes but killed neither the parental T lymphoma line nor the T lymphoma line transfected with Jas genes in which the cytoplasmic domain is truncated. On the other hand, these T lymphoma lines showed the same levels of susceptibility to CTLs specific for H-2 a alloantigens. Thus, these experimental results may permit us to conclude that Fas antigen and subsequent signaling from Fas are directly involved in the killing by NKI.1 + TCR-oe/3 l~ thymocytes. A similar killing system via Fas molecule was reported by Rouvier et al. (39) . These authors reported that certain kinds of CTLs which had been stimulated with target antigens in vivo showed both Fas-and non-Fas-mediated cytolysis. Rat Fas ligand was cloned from a novel (rat x mouse) T cell hybridoma and demonstrated to be a molecule of TNF family (40) . Although we attempted to detect Fas ligand expression on NKI.1 + TCR-oL/B l~ thymocytes using a soluble form of recombinant Fas molecules, we could not detect the expression of the Fas ligand on the effector cells (data not shown). Suda et al. (40) reported that stimulation of rat spleen cells with Con A significantly increased mRNA for the Fas ligand. Therefore, activation of T cells seems to elevate levels of the Fas ligand expression, which eventually results in induction of Fas-mediated CTL. Thus, the expression of Fas ligand on freshly isolated NKI.1 + TCR-c~/~ l~ thymocytes might not reach a detectable level when we analyzed them in the present study. Alternatively, NKI.1 § TCR-c~/~ § thymocytes may deliver signals to Fas molecules using unknown molecules different from the integral membrane Fas ligand. These points should be pursued in further studies in which more efficient detection system of routine Fas ligand is introduced.
At present, it has remained unclear whether recognition of antigens by TCR is involved in the cytotoxicity by NKI.1 § TCR-c~/~ I~ thymocytes against CD4 + 8 + thymocytes. The NKI.1 + TCR-c~/3 l~ thymocytes express skewed TCR V3 family and express self Mls-1 ~ reactive V38.1 TCR in Mls-1 a mice (1, 2, 5, 12 ). Recent analysis of 32-microglobulin deficient mice revealed that the predominant V~8.2 expression in C D 4 -8 -TCR-oJ3 + thymocytes results from positive selection by self-antigen presented on MHC class I (41) . Similarly, we have found that the proportion of NKI.1 § CD4 + 8-TCR-c~/3 l~ thymocytes is significantly reduced in 32-microglobulin-deficient mice (Arase, H., N. Arase, and K. Ono6, unpublished observation). It seems that the NKI.1 + TCR-cr/3 l~ thymocytes may recognize certain antigens associated with class I antigen in the absence of CD8 coreceptors and in this way acquire Fas-mediated cytotoxicity against CD4 +8 + thymocytes. However, it should be taken into consideration that the cytotoxicity by NKI.1 + TCR-cr l~ thymocytes was shown to cross the H-2 barrier and that CD4+8 § target thymocytes express low amounts of classical class I antigen.
Thymocytes are known to be positively or negatively selected and most of thymocytes die by apoptosis before they mature into CD4+8 -or CD4-8 + thymocytes from CD4+8 + thymocytes. We demonstrated herein that a subpopulation of CD4 +8 + thymocytes appeared to be targets for NKI.1 + TCR-c~/3 l~ killer cells in vitro. Thus, it seemed that NKI.1 + T C R -c r l~ thymocytes might contribute to the negative selection in the thymus. However, T cells with endogenous superantigen reactive TCR repertoire are almost normally eliminated in lpr mice (42) (43) (44) . Similarly, the T cells with self-reactive TCR have been already eliminated in newborn mice in which NKI.1 § TCR-c~/3 § thymocytes are hardly detected. Thus, it seems to us that the cytotoxicity of the NKI.1 + TCR-oJ3 I~ thymocytes toward immature thymocytes is not directly related to the clonal elimination of self-reactive T cells.
In Ipr and gld mice, abnormal B220 + C D 4 -8 -TCRot/3 ~ cells accumulate in lymphoid tissues of adult mice.
Although the exact origin of the B220 + CD4-8-T cells is unclear, several reports have suggested that these cells are derived from CD4 § 8 + thymocytes (42, (45) (46) (47) . Thus, the defect of cytotoxicity of NKI.1 § TCR-c~/~ + thymocytes against CD4+8 § thymocytes may be correlated with abnormal T cell development in Ipr and gld mice. In addition, a high production rate of whole CD4 § 8 + thymocyte population as compared with normal mice has been reported in Ipr mice (45) .
Both C D 4 -8 -NKI.1 § TCR-cff3 I~ and CD4+8 -NKI.1 + TCR-od3 l~ thymocytes appear late in life (1, 5, 12) . On the other hand, it was shown that culture of TCRc~/3-cells in bone marrow generated in C D 4 -8 -TCRot/3 § cells (48, 49) . Furthermore, Kikly and Dennert (50) reported that NKI.1 + C D 4 -8 -TCR-od3 ~~ T cells in bone marrow could differentiate in extrathymic tissues. Thus, it seems that the NKI.1 + CD4-8-TCK-c~IB + thymocytes are generated not only in the thymus (51) but also in extrathymic tissues. The latter population may enter the thymus after full differentiation. Indeed, it has been reported that activated T cells can enter the thymus (52, 53) . Taken together, these cells seem to have differentiated in a way different from major CD4 + or CD8 + T cells. Furthermore, proportions of NKI.1 + T cells are relatively high in the thymus (4, 12) , bone marrow (12, 54) , and liver (reference 55 and Arase, H., unpublished observation), although the NKI.1 + TCR-ot/fl l~ cells are detectable in almost all lymphoid organs. Thus, the target cells killed by the NKI.1 + TCRor//3 l~ T cells may not be restricted to CD4+8 + thymocytes. Further analysis of the NKI.1 + TCR-c~//3 + cells distributed to a variety of tissues will be needed to clarify the total functions of the cells.
A T cell population similar to that shown in the murine system has been reported in human. In the thymus (56) and peripheral blood (57) , T cells with natural killer cell marker such as CD56 (NKH-1) have been detected. In addition, human CD4-8-TCR-ot/13 § cells express unique TCR repertoire like murine CD4-8-TCR-ot/fl l~ T cells (58, 59 ) and a certain repertoire among these CD4-8-TCRa/B + cells has been shown to be specific for class I-like CD1 molecules (60) . On the other hand, Fas antigen is also expressed on most of the human thymocytes (Yonehara, S., Y. Kobayashi, and Y. Nishimura, manuscript submitted for publication). Therefore, the similar regulatory mechanism mediated by NK-like T cells may play a role even in human system.
In conclusion, we have demonstrated herein that freshly isolated NKI.1 + TCR-cc/B l~ thymocytes kill directly CD4 + 8 + thymocytes expressing Fas antigens. Although we have not elucidated the recognition system of the NKI.1 § TCR-ot/~ l~ cells, these findings appear to be important when the physiological role of NKI.1 + TCR-ot/fl l~ thymocytes and the Fas antigen expressed on most thymocytes are considered. The defective interaction between NKI.1 § TCR-ot//3 l~ killer thymocytes and target CD4 + 8 + thymocytes seems to be related to lymphoid disorders seen in both lpr and gld mice (33, 35) .
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